The effects of extremely low frequency magnetic fields (ELF-MFs) on physiological processes at the cellular level remain unclear despite a number of studies. To investigate the effects of ELF-MFs on gene expression, we exposed human mammary epithelial MCF10A cells to fields of 1 mT magnetic flux density at 60 Hz for 4 and 16 h and measured the transcriptional responses of 24,000 genes using Illumina microarrays. In three independent experiments, we found no statistically significant alteration of expression levels for any of the genes assayed using a cutoff value of 1.2-fold. To confirm this result, we selected six genes with trends suggesting possible expression level changes, although these trends were not statistically significant, and investigated their expression levels further using a semiquantitative reverse-transcription polymerase chain reaction. In three independent experiments, we did not find any alterations in the expression levels of these genes. From these results, we conclude that ELF-MFs do not affect gene expression profiles under our exposure conditions.
Ⅰ. Introduction
Extremely low frequency magnetic fields (ELF-MFs) ranging from 3 to 300 Hz are generated by high-voltage electrical power transmission lines and secondary distribution lines. Concerns are frequently raised among the general public regarding possible adverse health effects associated with ELF-MF exposure. Over the last three decades, many research groups have conducted studies to determine the effects of ELF-MFs on biological systems. Epidemiological studies reported a link between the risks of various cancers, particularly childhood leukemia, and ELF-MF exposure [1] . Other studies suggested that exposure to magnetic fields (MFs) due to regular proximity to electrical power lines or occupational demands increased the risks of cardiovascular disease and Alzheimer's disease [2] , [3] . In vitro studies have shown that ELF-MF could influence cell proliferation and cytoskeletal organization, and could induce DNA damage through the action of free radical species [4] ～ [6] . Martínez et al. reported that ELF-MF could stimulate proliferative activity in neuronal cells by triggering MAPK-ERK1/2 signaling [7] . It has been also reported that electromagnetic fields (EMF) transiently influence the transcript level of genes related to apoptosis and the cell cycle [8] , [9] . However, in vitro studies failed to demonstrate any biological effects of ELF-MFs [10] ～ [13] . Magnetic fields have no significant effects on levels of stress proteins, cytoskeleton proteins, and the proliferation of astroglial cells [14] . ELF-MF has no effect on intracellular ROS level, SOD activity, and the ratio of GSH/GSSG in MCF10A cells [15] . Because of these apparently conflicting results, the biological effects of ELF-MF exposure remain an open question.
Although the radical pair mechanism has been suggested as a candidate, a fundamental mechanism of interaction between ELF-MFs and biological systems has not been demonstrated [10] . If ELF-MF exposure could modulate cellular processes such as proliferation, apoptosis, and differentiation, it might be mediated through alterations of gene expression. Altered gene expression could also serve as a useful biomarker for MF exposure. Most studies examining the response of expression levels to MF exposure have only looked at small numbers of genes [11] ～ [13] . High-throughput transcriptomics and proteomics could identify putative molecular targets and the possible molecular mechanisms of EMF exposure where previous studies of small numbers of genes have failed to do so [16] , [17] . A microarray containing the entire human transcriptome permits a much more thorough investigation of potential changes in transcription levels compared with classical methodologies [18] .
The aim of this study was to examine alterations in the expression profile of the human genome following ELF-MF exposure. We investigated the transcriptional response of MCF10A human breast epithelial cells exposed to 1 mT ELF-MFs at 60 Hz using microarrays containing 24,000 human genes.
Ⅱ. Materials and Method

2-1 Cell Culture
A MCF10A human breast epithelial cell line was purchased from the American Type Culture Collection (ATCC) (Manassas, USA). The cells were routinely maintained in a 1:1 mix of DMEM and Ham's F12 media (Invitrogen, Carlsbad, USA) supplemented with 5 % horse serum (Invitrogen), 100 μg/ml of streptomycin and 100 U/ml of penicillin (WelGENE, Daegu, Korea), 11.2 μg/ml insulin (Sigma, St. Louis, USA), 21 ng/ml epidermal growth factor (Peprotech, Rocky Hill, USA), 50 ng/ml cholera toxin (Sigma), and 525 ng/ml Hydrocortisone (Sigma) in a humidified atmosphere containing 5 % CO2.
2-2 Exposure System and Exposure to ELF MF
The MF generation equipment was designed and constructed by Korea Electrotechnology Research Institute as described in Hong et al. [15] . The field generator consists of four square-shaped coils and one cage with three testing floors (a top, middle, and bottom floor) as shown in Fig. 1(a) . The voltage fluctuation rate and harmonic rate of power quality using power amplifier was under 1 %. Fixing the magnetic field at the center of the middle floor was 1 mT. The spatial variation of magnetic field was under 3 %. This strongly demonstrates that the field generator is good for a small-sized in vitro study. The total ELF-MF exposure system, in- cluding the cell culture incubator, is demonstrated in Fig. 1(b) . The temperature of the incubator was maintained at 37±0.3 ℃ during the exposure period using a water-jet cooling system. The magnetic field shielding system using ferrite material was adopted to shield the strong magnetic field in the outer ELF-MF exposure system. We used two exposure systems (a sham exposure system and ELF-MF exposure system) for this study. The ELF-MF exposure system was warmed up for 15 min to equilibrate it prior to exposure. Cells in the 100 mm Petri dish were exposed to 60 Hz at 1 mT intensity for 4 h or 16 h. For the sham exposure, cells were kept in the ELF-MF exposure system without MF generation. The temperature was maintained at 37±0.3 ℃ throughout the exposure period in both the shamexposed and ELF-MF-exposed groups.
2-3 RNA Preparation
Total RNA was extracted using Trizol (Invitrogen Life Technologies, Carlsbad, USA) and was purified using RNeasy columns (Qiagen, Valencia, USA) according to the manufacturers' protocol. After DNase digestion and clean-up procedures, RNA samples were quantified, aliquoted, and stored at -80 ℃ until being utilized. For quality control, RNA purity and integrity were evaluated by denaturing gel electrophoresis, and analyzed OD 260/280 ratio using Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, USA).
2-4 Microarray Analysis
Total RNA was amplified using the Ambion Illumina RNA amplification kit (Ambion, Austin, USA) to yield biotinylated cRNA according to the manufacturer's instructions. Briefly, 550 ng of total RNA was reversetranscribed to cDNA using a T7 oligo (dT) primer. Second-strand cDNA was synthesized, in vitro transcribed, and labeled with biotin-NTP. After purification, cDNA was quantified using the ND-1000 Spectrophotometer (NanoDrop, Wilmington, USA) and 750 ng of labeled cDNA samples were hybridized to each HumanRef-8 Expression Beadchip (Illumina Inc., San Diego, USA) containing more than 24,000 oligonucleotide probes for 16～18 h at 58 ℃, according to the manufacturer's instructions. Detection of the array signal was accomplished by using Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following the bead array manual. Arrays were scanned with an Illumina bead array reader confocal scanner (Illumina Inc., San Diego, USA). Array data export processing and analysis is performed using Illumina Genome Studio v2009.2 (Gene Expression Module v1.5.4).
2-5 Raw Data Preparation and Statistic Analysis
The quality of hybridization and overall chip performance were monitored through visual inspection of both internal quality control checks and the raw scanned data. Raw data were extracted using the software provided by the manufacturer (Illumina GenomeStudio v2009.2; Gene Expression Module v1.5.4). Array data were filtered by detection p-value<0.05 (similar to signal to noise) in at least 50 % of the samples (we applied a filtering criterion for data analysis; a higher signal value was required to obtain a detection p-value<0.05). The selected gene signal value was transformed with a logarithm and normalized by applying the quantile method. The statistical significance of the expression data was determined using the Paired t-test in which the null hypothesis was that no difference exists between the mean of the groups used in the data pool. False discovery rate (FDR) was controlled for by adjusting the p-value using the Benjamini-Hochberg algorithm. Goontology analysis for probe list was performed using PANTHER (http://www.pantherdb.org/panther/ontologies. jsp), using text files containing a Gene ID list, and the accession number of Illumina probe ID. Gene Set Enrichment Analysis (GSEA) was performed whether a priori defined set of genes showed a differential pattern between both biological process and molecular function states. One-tail Fisher Exact was adopted to measure the gene enrichment in annotation terms. Hierarchical clustering was performed using complete linkage with a Euclidian metric. GenomeStudio v2009.2 software was used for quantification and image analysis of mRNA data. R scripts were used for all other analytical process. The final RT-PCR products were electrophoresed on 2.0 % agarose gel, stained with 0.5 g/ml ethidium bromide solution, and visualized on a UV transilluminator (BioRad Laboratories, Hercules, CA). In this system, PCR products were quantified using Gel-Doc (Bio-Rad Laboratories, Hercules, CA).
2-7 Statistical Analysis
All values are expressed as mean±SD. The student's t-test was performed with Origin 6.0 (Origin Lab, Northampton, USA). A p-value less than 0.05 was considered significant.
Ⅲ. Results
3-1 High-Throughput Gene Expression Profile of ELF-MF-Exposed MCF10A Cells
As outlined in Fig. 2 , MCF10A cells were exposed to 1 mT ELF-MFs at 60 Hz for 4 and 16 h. The cells showed no microscopically detectable changes in cellular morphology compared with sham-exposed cells (Fig. 3) . To identify genes that were affected by ELF-MF exposure, we performed three independent replicate microarray analyses for sham-and ELF-MF-exposed MCF 10A cells after 4 h and 16 h exposures, including ELF-MF exposure, sample preparation, and hybridization, in order to obtain a reproducible list of altered genes. Therefore, we ran a total of 12 microarray experiments and determined the statistical significance of the expression data using paired t-tests. Initially, we chose a change in the expression level of 1.5-fold, a commonly used cutoff value in microarray analysis, as our cutoff value. However, we did not find any genes with statistically significant 1.5-fold alterations in the expression level. So we performed the analysis using a cutoff value of 1.2-fold and still found no statistically significant changes in the expression level of any gene (Fig. 2) .
3-2 Validation of High-Throughput Results Using RT-PCR
In order to reduce the likelihood that our failure to find any impact on gene expression from ELF-MF exposure was due to statistical limitations, we conducted further analysis of a small number of genes using semi-quantitative RT-PCR (sqRT-PCR). Using relaxed criteria to identify differentially expressed genes, we selected 14 genes that exhibited statistically non-significant trends for altered expression levels (|average fold change|>1.2) both at the 4 and at 16 h of ELF-MF exposure (Table 1) . We randomly selected six of the fourteen genes in Table 1 : coagulation factor III (F3), interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), ARP3 actin-related protein 3 homology (AC-TR3), cyclin H (CCNH), protein kinase, cAMP-dependent, regulatory, type I, alpha (PRKAR1A), and NEDD8 activating enzyme E1 subunit 1 (NAE1).
We preformed three replicate sqRT-PCR experiments with independent ELF-MF exposures and RNA extractions (Fig. 4) . We used the expression level of GAPDH as a baseline to quantify and normalize the PCR signal intensities of the selected genes. Fig. 4 shows the mean ±standard deviation (M±SD) of each mRNA level in the ELF-MF-exposed cells relative to that of the sham-exposed cells. The sqRT-PCR results confirmed that the expression levels of the six selected genes were not altered by EMF-MF exposure.
Ⅳ. Discussion
We conducted microarray analysis to elucidate the effects of ELF-MF exposure on gene expression. Using high-throughput analysis, we found that genome-wide expression levels in MCF10A human breast epithelial cells were not changed by exposure to ELF-MFs. To confirm these results, we performed sqRT-PCR on six genes selected from the microarray analysis that exhibited statistically non-significant trends for expression changes; the follow-up results confirmed those of the Previous studies reported that ELF-MF exposure could affect transcription levels in vitro of several immediate-response genes [8] , [19] ～ [21] . These studies, however, only looked at a few genes and their results require further confirmation before firm conclusions can be drawn. Recent technical advances now make it possible to simultaneously monitor the expression of thousands of genes across entire genomes. Such high-throughput technology has the potential to resolve the uncertainties about whether ELF-MF exposure is harmful to biological systems. Additionally, it could help to elucidate the biological mechanisms and pathways affected by MFs [1]. Several groups have conducted analyses using high-throughput technologies to determine the biological effects of ELF-MF exposure. Loberg et al. [22] found, using arrays containing cDNAs, that MF exposure did not affect the expression of 588 cancer-related genes. They performed three independent exposures of normal (HME) and transformed (HBL-100) human mammary epithelial cells and human promyelocytic leukemia (HL60) cells to 0.01 or 1 mT MFs at 60 Hz for 24 h. In the same year, Balcer-Kubiczek et al. [23] exposed 960 cDNA clones to 2 mT MFs at 60 Hz for 24 h and found no effect on the expression levels of the selected genes. Luceri et al. [18] In contrast to the negative results mentioned above, Zhao et al. [24] used rat oligo osteogenesis microarrays to show that Bmp1 (bone morphogenic protein) and Bmp7 mRNAs were up-regulated, whereas Egf (epidermal growth factor) and Egfr (epidermal growth factor receptor) mRNAs were down-regulated, in Sprague Dawley rat bone-marrow mesenchymal stem cells exposed to EMFs (15 Hz, 1 mT, 5 h/d) for 2 days. They reported that these altered genes could be involved in diverse biological processes such as skeletal development, bonemineral metabolism, cell growth and differentiation, cell adhesion, and so forth Two other groups conducted microarray analyses of cells exposed to ELF electrical fields (EFs), instead of ELF-MFs, and demonstrated a modified expression of Bmp, Dickkopf-related protein 1 (DKK1), thioredoxin reductase 1 (TXNRD1), cyclic AMPdependent transcription factor 3 (ATF3), membrane metallo-endopeptidase (MME), and microtubule-actin crosslinking factor 1 (MACF1) in human epidermal cells [19] , [25] .
In our study, we tried to identify up-or downregulated genes using a cutoff value of 1.2-fold. None of these genes, however, was significantly (p<0.05) upor down-regulated when the results of all three independent experiments were considered together. Therefore, we did not obtain conclusive evidence of altered gene expression following ELF-MF exposure. These results suggest that observations of ELF-MF-induced changes in expression levels based on single experiments might be spurious and should be confirmed with replicate experiments; this is consistent with the conclusions of previous reports published by Loberg et al. [22] and Henderson et al. [1] .
Microarray technology has advanced tremendously in recent years; however, the potential for misleading results remains. Microarrays have the power to evaluate the expression of many genes simultaneously and without proper experimental design, it is sometimes impossible to distinguish important results from random fluctuations. Because it is designed to detect small changes in gene expression profiles, microarray technology is sensitive enough to reflect subtle alterations in sample preparation procedures, environmental conditions, or experimental procedures [18] . Therefore, we suggest that microarray experiments should be conducted with at least three-fold replication to establish the reproducibility of their results. Additionally, the results of microarray experiments should be validated using reverse transcription polymerase chain reaction (RT-PCR) whenever possible. So far, only a few research groups have reported results from high-throughput analyses of the effects of ELF-MF exposure on transcription; more studies will be required to conclusively determine the biological effects of ELF-MF exposure. 
